Myocardial and anti‐inflammatory effects of chronic bosentan therapy in monocrotaline‐induced pulmonary hypertension | Revista Portuguesa de Cardiologia (English edition)

Statistics

Original Article

Myocardial and anti‐inflammatory effects of chronic bosentan therapy in monocrotaline‐induced pulmonary hypertension

Efeitos miocárdicos e anti‐inflamatórios da terapêutica crónica com bosentan na hipertensão pulmonar experimental

Dulce Fontouraa,1, José Oliveira‐Pintoa,1, Marta Tavares‐Silvaa,b, Sara Leitea, Francisco Vasques‐Nóvoaa,c, Pedro Mendes‐Ferreiraa, André P. Lourençoa,d,

Corresponding author

aplourenco@yahoo.com

Corresponding author.

, Adelino F. Leite‐Moreiraa,e

a Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal

b Department of Cardiology, São João Hospital Centre, E.P.E., Porto, Portugal

c Department of Internal Medicine, São João Hospital Centre, E.P.E., Porto, Portugal

d Department of Anaesthesiology, São João Hospital Centre, E.P.E., Porto, Portugal

e Department Cardiothoracic Surgery, São João Hospital Centre, E.P.E., Porto, Portugal

Read

6907

Times
was read the article

2032

Total PDF

4875

Total HTML

Share statistics

Article information

ISSN: 21742049
Original language: English

DOI:10.1016/j.repce.2013.09.019

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	12	13	25
2025 5	58	27	85
2025 4	53	30	83
2025 3	61	20	81
2025 2	36	19	55
2025 1	42	30	72
2024 12	28	20	48
2024 11	57	36	93
2024 10	31	36	67
2024 9	34	22	56
2024 8	41	24	65
2024 7	28	29	57
2024 6	36	21	57
2024 5	33	25	58
2024 4	34	30	64
2024 3	34	13	47
2024 2	38	18	56
2024 1	29	25	54
2023 12	31	22	53
2023 11	28	28	56
2023 10	17	15	32
2023 9	23	33	56
2023 8	60	17	77
2023 7	24	10	34
2023 6	15	16	31
2023 5	40	29	69
2023 4	33	6	39
2023 3	18	25	43
2023 2	22	19	41
2023 1	24	18	42
2022 12	35	22	57
2022 11	38	26	64
2022 10	28	16	44
2022 9	40	31	71
2022 8	37	23	60
2022 7	46	34	80
2022 6	24	24	48
2022 5	30	36	66
2022 4	31	21	52
2022 3	34	37	71
2022 2	37	25	62
2022 1	29	26	55
2021 12	19	32	51
2021 11	30	33	63
2021 10	40	32	72
2021 9	28	20	48
2021 8	33	28	61
2021 7	27	24	51
2021 6	31	23	54
2021 5	45	38	83
2021 4	50	27	77
2021 3	46	22	68
2021 2	43	11	54
2021 1	29	11	40
2020 12	31	8	39
2020 11	28	19	47
2020 10	27	20	47
2020 9	36	6	42
2020 8	17	6	23
2020 7	47	7	54
2020 6	32	7	39
2020 5	41	4	45
2020 4	36	12	48
2020 3	32	13	45
2020 2	102	26	128
2020 1	39	8	47
2019 12	27	4	31
2019 11	28	2	30
2019 10	38	4	42
2019 9	18	12	30
2019 8	27	1	28
2019 7	21	27	48
2019 6	12	14	26
2019 5	39	4	43
2019 4	28	12	40
2019 3	98	12	110
2019 2	116	13	129
2019 1	65	10	75
2018 12	95	19	114
2018 11	153	16	169
2018 10	448	17	465
2018 9	70	14	84
2018 8	34	7	41
2018 7	20	14	34
2018 6	27	8	35
2018 5	21	13	34
2018 4	44	22	66
2018 3	24	11	35
2018 2	27	4	31
2018 1	19	6	25
2017 12	47	11	58
2017 11	28	12	40
2017 10	34	15	49
2017 9	31	16	47
2017 8	41	17	58
2017 7	36	12	48
2017 6	21	5	26
2017 5	35	5	40
2017 4	45	8	53
2017 3	39	19	58
2017 2	35	2	37
2017 1	36	3	39
2016 12	43	8	51
2016 11	17	5	22
2016 10	18	2	20
2016 9	13	8	21
2016 8	2	2	4
2016 7	6	3	9
2016 6	2	6	8
2016 5	4	3	7
2016 4	14	1	15
2016 3	19	8	27
2016 2	33	17	50
2016 1	19	13	32
2015 12	23	7	30
2015 11	21	12	33
2015 10	25	12	37
2015 9	31	8	39
2015 8	21	8	29
2015 7	27	7	34
2015 6	12	0	12
2015 5	12	3	15
2015 4	22	4	26
2015 3	13	3	16
2015 2	13	4	17
2015 1	20	3	23
2014 12	33	6	39
2014 11	15	8	23
2014 10	30	5	35
2014 9	25	4	29
2014 8	25	9	34
2014 7	33	16	49
2014 6	39	12	51

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter